LUTS Surgery Does Not Cause Prostate Cancer
Surgical treatment for lower urinary tract symptoms (TURP, HoLEP, etc.) does not increase the risk of developing prostate cancer. These procedures treat benign prostatic obstruction and may incidentally detect pre-existing cancer, but they do not cause malignancy.
The Key Distinction: Detection vs. Causation
The evidence clearly shows that prostate surgery for LUTS detects rather than causes prostate cancer:
- Incidental prostate cancer (iPCa) is found in approximately 2-11% of patients undergoing LUTS surgery 1, 2
- In one series of 98 HoLEP patients, only 2.1% had incidental cancer detected 1
- A larger study of 577 HoLEP patients found iPCa in 2.77% of cases 2
- Another cohort reported 11.1% incidental detection rate 3
These cancers existed before surgery—the procedure simply removed tissue that was then examined pathologically, revealing previously undiagnosed malignancy.
What the Guidelines Say
The most recent EAU guidelines 4, 5 focus on patient selection, surgical risks, and outcomes for BPO/LUTS surgery. Notably, increased cancer risk is not mentioned as a complication or concern in these comprehensive 2023-2025 guidelines. The guidelines emphasize:
- Shared decision-making based on symptom severity and quality of life impact
- Risk-benefit assessment for surgical complications (bleeding, stricture, incontinence)
- Patient expectations and preferences
If LUTS surgery increased prostate cancer risk, this would be prominently featured in guidelines—it is not.
Clinical Implications
For Patients Without Known Prostate Cancer:
- Proceed with indicated LUTS surgery without concern about causing cancer 4, 5
- Pre-operative PSA testing is recommended if cancer detection would change management 5
- Multiparametric MRI screening may identify occult cancer in surgical candidates 3
For Patients With Known Low-Risk Prostate Cancer on Active Surveillance:
- LUTS surgery can be safely performed when symptoms are bothersome 6
- Contemporary evidence shows BPH interventions do not adversely affect oncologic outcomes 6
- Post-operative surveillance with PSA and MRI remains feasible 3
Incidentally Detected Cancers:
- Most iPCa cases are clinically insignificant (Gleason Grade Group 1) 2
- In one study, only 1 of 16 iPCa cases was clinically significant 2
- These patients can typically be managed with active surveillance or watchful waiting 3, 2
Common Pitfall to Avoid
Do not delay necessary LUTS surgery due to unfounded concerns about causing prostate cancer. The real risk is allowing severe urinary symptoms to persist, compromising quality of life, when safe and effective surgical options exist. The incidental detection of cancer during surgery may actually benefit patients by identifying disease earlier than it would otherwise have been diagnosed.